David R Roalf1, Raquel E Gur2, Ragini Verma3, William A Parker3, Megan Quarmley4, Kosha Ruparel4, Ruben C Gur2. 1. Neuropsychiatry Section, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, United States. Electronic address: roalf@upenn.edu. 2. Neuropsychiatry Section, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, United States; Department of Radiology, University of Pennsylvania Perelman School of Medicine, United States. 3. Department of Radiology, University of Pennsylvania Perelman School of Medicine, United States. 4. Neuropsychiatry Section, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, United States.
Abstract
BACKGROUND: Diffusion tensor imaging (DTI) studies in schizophrenia report widespread aberrations in brain white matter (WM). These appear related to poorer neurocognitive performance and higher levels of negative and positive symptomatology. However, identification of the most salient WM aberrations to neurocognition and clinical symptoms is limited by relatively small samples with divergent results. METHODS: We examined 53 well-characterized patients with schizophrenia and 62 healthy controls. All participants were administered a computerized neurocognitive battery, which evaluated performance in several domains. Patients were assessed for negative and positive symptoms. Fractional anisotropy (FA) of WM cortical regions and WM fiber tracts were compared across the groups. FA values were also used to predict neurocognitive performance and symptoms. RESULTS: We confirm widespread aberrant WM microstructure in a relatively large sample of well-characterized patients with schizophrenia in comparison to healthy participants. Moreover, we illustrate the utility of FA measures in predicting global neurocognitive performance in healthy participants and schizophrenia patients, especially for reaction time. FA was less predictive of clinical symptomatology. CONCLUSIONS: Using a standardized computerized neurocognitive battery and diffusion tensor imaging we show that behavioral performance is moderated by a particular constellation of WM microstructure in healthy individuals that differs in schizophrenia.
BACKGROUND: Diffusion tensor imaging (DTI) studies in schizophrenia report widespread aberrations in brain white matter (WM). These appear related to poorer neurocognitive performance and higher levels of negative and positive symptomatology. However, identification of the most salient WM aberrations to neurocognition and clinical symptoms is limited by relatively small samples with divergent results. METHODS: We examined 53 well-characterized patients with schizophrenia and 62 healthy controls. All participants were administered a computerized neurocognitive battery, which evaluated performance in several domains. Patients were assessed for negative and positive symptoms. Fractional anisotropy (FA) of WM cortical regions and WM fiber tracts were compared across the groups. FA values were also used to predict neurocognitive performance and symptoms. RESULTS: We confirm widespread aberrant WM microstructure in a relatively large sample of well-characterized patients with schizophrenia in comparison to healthy participants. Moreover, we illustrate the utility of FA measures in predicting global neurocognitive performance in healthy participants and schizophreniapatients, especially for reaction time. FA was less predictive of clinical symptomatology. CONCLUSIONS: Using a standardized computerized neurocognitive battery and diffusion tensor imaging we show that behavioral performance is moderated by a particular constellation of WM microstructure in healthy individuals that differs in schizophrenia.
Authors: Yan Cao; Michael I Miller; Susumu Mori; Raimond L Winslow; Laurent Younes Journal: Proc IEEE Comput Soc Conf Comput Vis Pattern Recognit Date: 2006-07-05
Authors: Paula L Croxson; Heidi Johansen-Berg; Timothy E J Behrens; Matthew D Robson; Mark A Pinsk; Charles G Gross; Wolfgang Richter; Marlene C Richter; Sabine Kastner; Matthew F S Rushworth Journal: J Neurosci Date: 2005-09-28 Impact factor: 6.167
Authors: Kelly Rowe Bijanki; Brendan Hodis; Vincent A Magnotta; Eugene Zeien; Nancy C Andreasen Journal: Schizophr Res Date: 2014-06-20 Impact factor: 4.939
Authors: Paul G Nestor; Marek Kubicki; Kevin M Spencer; Margaret Niznikiewicz; Robert W McCarley; Martha E Shenton Journal: Schizophr Res Date: 2006-12-05 Impact factor: 4.939
Authors: Ruben C Gur; Monica E Calkins; Theodore D Satterthwaite; Kosha Ruparel; Warren B Bilker; Tyler M Moore; Adam P Savitt; Hakon Hakonarson; Raquel E Gur Journal: JAMA Psychiatry Date: 2014-04 Impact factor: 21.596
Authors: Serge A Mitelman; Emily L Canfield; Randall E Newmark; Adam M Brickman; Yuliya Torosjan; King-Wai Chu; Erin A Hazlett; M Mehmet Haznedar; Lina Shihabuddin; Monte S Buchsbaum Journal: Open Neuroimag J Date: 2009-05-20
Authors: Richard Kanaan; Gareth Barker; Michael Brammer; Vincent Giampietro; Sukhwinder Shergill; James Woolley; Marco Picchioni; Timothea Toulopoulou; Philip McGuire Journal: Br J Psychiatry Date: 2009-03 Impact factor: 9.319
Authors: Anne M Merrill; Nicole R Karcher; David C Cicero; Theresa M Becker; Anna R Docherty; John G Kerns Journal: Psychiatry Res Date: 2017-01-06 Impact factor: 3.222
Authors: Paul Klauser; Simon T Baker; Vanessa L Cropley; Chad Bousman; Alex Fornito; Luca Cocchi; Janice M Fullerton; Paul Rasser; Ulrich Schall; Frans Henskens; Patricia T Michie; Carmel Loughland; Stanley V Catts; Bryan Mowry; Thomas W Weickert; Cynthia Shannon Weickert; Vaughan Carr; Rhoshel Lenroot; Christos Pantelis; Andrew Zalesky Journal: Schizophr Bull Date: 2017-03-01 Impact factor: 9.306
Authors: Johanna Seitz-Holland; Joanne D Wojcik; Suheyla Cetin-Karayumak; Amanda E Lyall; Ofer Pasternak; Yogesh Rathi; Mark Vangel; Godfrey Pearlson; Carol Tamminga; John A Sweeney; Brett A Clementz; David A Schretlen; Petra Verena Viher; Katharina Stegmayer; Sebastian Walther; Jungsun Lee; Tim Crow; Anthony James; Aristotle Voineskos; Robert W Buchanan; Philip R Szeszko; Anil K Malhotra; Sinead Kelly; Martha E Shenton; Matcheri S Keshavan; Raquelle I Mesholam-Gately; Marek Kubicki Journal: Mol Psychiatry Date: 2022-08-18 Impact factor: 13.437
Authors: David R Roalf; J Eric Schmitt; Simon N Vandekar; Theodore D Satterthwaite; Russell T Shinohara; Kosha Ruparel; Mark A Elliott; Karthik Prabhakaran; Donna M McDonald-McGinn; Elaine H Zackai; Ruben C Gur; Beverly S Emanuel; Raquel E Gur Journal: Psychiatry Res Neuroimaging Date: 2017-08-24 Impact factor: 2.376
Authors: David R Roalf; Megan Quarmley; Mark A Elliott; Theodore D Satterthwaite; Simon N Vandekar; Kosha Ruparel; Efstathios D Gennatas; Monica E Calkins; Tyler M Moore; Ryan Hopson; Karthik Prabhakaran; Chad T Jackson; Ragini Verma; Hakon Hakonarson; Ruben C Gur; Raquel E Gur Journal: Neuroimage Date: 2015-10-28 Impact factor: 6.556